There is increasing evidence that the enthesis organ and biomechanically related structures may be important sites for disease initiation in spondyloarthritis (SpA) (1, 2) . In animal models, including models of interleukin-23 (IL-23) and tumor necrosis factor overexpression, primary entheseal disease results in subsequent spreading to the adjacent synovium and bone (1, 3) . Until recently, the enthesis, with its avascular region of fibrocartilage at the bone interface and adjacent tendon, ligament, or capsules that are composed of fibrocartilage and dense stromal connective tissue, was not studied as an immune organ. However, the seminal work of Sherlock and colleagues showed that normal murine enthesis had an IL-23-dependent population of cells that, although rare, are nevertheless critical to SpA pathogenesis (1) .
The description of a family of cytokinedependent innate lymphoid cells (ILCs) that play a pivotal role in barrier tissue homeostasis, repair, and inflammation (4,5) has led to major new avenues for investigation of inflammatory disease immunopathogenesis. In recent years, the importance of ILCs in the gut and skin (both targets of SpA in humans) has been reported, with a possible role of these cells in tissue repair and homeostasis (4, 5) . Since the normal mechanically stressed human enthesis is a site of microdamage and microscopic inflammation in normal aged enthesis, it is feasible that the human enthesis under physiologic conditions may also contain ILCs.
In humans, ILCs can be broadly subdivided into 3 main categories: group 1 ILCs (ILC1s), which are defined by their ability to produce interferon-g, ILC2s, which are able to produce Th2-associated cytokines, and an ILC3 subpopulation characterized by expression of the truncated retinoic acid receptor-related orphan nuclear receptor gt (RORgt) (5) . Human spondyloarthritides are genetically linked to the IL-23/IL-17 cytokine axis (6) , and therapeutic antagonism of this pathway is effective in SpA (6) . The ability of ILC3s to respond to IL-1b/IL-23 signaling with IL-17 and IL-22 production is especially relevant (5) . Additionally, ILC3s are comparatively abundant in synovial fluid (SF) from patients with SpA (7, 8) and have also been shown to be increased in psoriatic skin (9) and to play a pivotal role in gut homeostasis and in experimental inflammatory bowel disease (4, 5, 7) . Given the importance of ILC3s in human skin and gut in addition to emerging data from animal models, we hypothesized that the normal human enthesis harbors ILC3s with the potential for activation by local or systemic IL-23. Herein we describe methodology for the assessment of human entheseal immune populations under normal conditions and following immune stimulation and provide a preliminary characterization of human group 3 ILCs.
PATIENTS AND METHODS
Enthesis samples. Normal interspinous process enthesis was obtained from 13 patients (8 men and 5 women; median age 52 years) who were undergoing spinal decompression or surgery for correction of scoliosis of thoracic or lumbar vertebrae. Peripheral blood was also collected from these patients, as well as from 14 healthy controls (9 men and 5 women; median age 42 years). To compare entheseal ILC3s populations from normal subjects to those from patients with active inflammatory disease, SF samples from 4 patients with SpA and knee synovitis were also examined.
To determine whether ILCs might be present at sites of enthesis damage, injured enthesis was obtained from 3 patients undergoing surgical repair of ruptured Achilles tendons with tissue being procured from the perientheseal rupture site. Similarly, anterior cruciate ligament (ACL), which is known to be damaged by the osteoarthritic process, was obtained from 7 patients undergoing knee arthroplasty for the treatment of advanced osteoarthritis.
Digested enthesis immune cell cytometric evaluation. Since the earliest lesions in human SpA appear to occur either in the entheseal soft tissue or in sub-fibrocartilaginous bone (10), both entheseal soft tissue and perientheseal bone were initially separated ( Figure 1A ) and digested in collagenase solution as previously described (11) . Spinous process and interspinous ligament were harvested and transported in sterile saline. Processing took place immediately or after overnight storage at 48C, and was performed under sterile conditions. Using a scalpel, entheseal soft tissue was separated from perientheseal bone ( Figure 1A ). Entheseal soft tissue was then thoroughly minced using a scalpel, and its weight was recorded. Perientheseal bone tissue was broken up to ,5-mm 2 fragments using a bone nibbler (bone cutting forceps), and its weight was recorded. Entheseal soft tissue and perientheseal bone tissue were incubated for 3.5 hours at 378C with constant gentle agitation in a sterile solution of 20% fetal calf serum (FCS), 80% phosphate buffered saline (PBS), and 600 units/ ml collagenase (Worthington). Collagenase as supplied contained several isoforms of 2 different collagenases, a sulfhydryl protease, clostripain, a trypsin-like enzyme, and an aminopeptidase. The volume of collagenase solution applied to each sample in milliliters was $5-fold the sample weight in grams. Following digestion, samples were diluted 1:3 in PBS and passed through a 70-mm sterile filter; any material that could not pass through the filter was discarded. Samples were then centrifuged for 10 minutes at 400g, after which cells were resuspended in 10 ml Dulbecco's modified Eagle's medium (Sigma) and layered onto Lymphoprep solution (Axis-Shield). Cells were centrifuged for 20 minutes at 1,200g with no brake, and the buffy coat containing cells was transferred to a 50-ml centrifuge tube and diluted in .30 ml PBS. Cells were then centrifuged for 10 minutes at 400g and resuspended in sterile fluorescence-activated cell sorting buffer.
Mononuclear cells were isolated using a densitygradient medium (Lymphoprep). T cells, B cells, and natural killer (NK) cells were discriminated based on forward and side scatter characteristics and expression of CD45 and then CD3, CD19, and CD56, respectively. T cell subsets (T helper cells and cytotoxic T cells) were discriminated based on expression of CD4 and CD8, respectively. T cells that did not express CD4 or CD8 were also measured, and g/d T cells were identified based on expression of T cell receptor g/d (TCRg/d) (details available upon request from the corresponding author). Entheseal ILC subsets were discriminated based on expression of cell surface phenotype, i.e., ILC1: Lin-(CD1a, CD3, CD14, CD11c, CD19, CD34, CD94, CD123, CD303, Fce receptor 1, TCRa/b, TCRg/d), CD451, CD1271, chemoattractant receptor-like molecule expressed on Th2 (CRTH2)-, c-Kit-; ILC2: Lin-, CD1271, CD451, CRTH21; ILC3: Lin-, CD451, CD1271, CRTH2-, c-Kit1 (5,7,8) (additional details on the antibodies and processes used available upon request from the corresponding author). Dead cells were discriminated based on uptake of aqua dye (Thermo Fisher) or 7-aminoactinomycin D (BD Biosciences). An Influx fluorescence-activated cell sorter (BD Biosciences) was used to isolate entheseal ILC subsets. Immunophenotyping in unsorted samples was performed with an LSRII flow cytometer (BD Biosciences).
Transcript analysis before and after cytokine stimulation of entheseal digests. Changes in the expression of key IL-23/IL-17 axis cytokines were assessed in unsorted whole entheseal digests. Following digestion, 2 3 10 6 cells were incubated (378C, 5% CO 2 ) with Iscove's modified Dulbecco's medium (Gibco) containing 10% FCS (Biosera) in the presence or absence of IL-1b (10 ng/ml) and IL-23 (50 ng/ml) (both from Miltenyi Biotec). After 48 hours, cells were prepared for RNA isolation.
RNA was isolated using a PicoPure RNA isolation kit (Thermo Fisher), and complementary DNA was synthesized using a high-capacity reverse transcription kit (Thermo Fisher). Target transcripts were preamplified with a GE PreAmp kit (Fluidigm). (This step was omitted in cytokine stimulation assays.) Quantitative real-time polymerase chain reaction (PCR) with an ABI 7500 thermocycler (Applied Biosystems) was performed to measure expression of immunomodulatory and proinflammatory transcripts. Expression levels of all target genes were calculated relative to expression of the housekeeping gene HPRT1. Values below detection limits were not considered or plotted unless otherwise noted.
Histology and immunofluorescence microscopy. For immunofluorescence microscopy, frozen sections of healthy entheseal soft tissue were incubated with fluorescence-labeled antibodies against CD3 and RORgt and counterstained with DAPI. Tissue samples from Achilles tendon, ACL ( Figure 1B) , and spinous process were prepared for histologic analysis using standard protocols, stained with mouse anti-human RORgt and EnVision Plus horseradish peroxidase stain (Dako), and counterstained with Harris' hematoxylin.
Statistical analysis. The Kruskal-Wallis independent samples test was used to assess the significance of differences between peripheral blood, entheseal soft tissue, and perientheseal bone samples with regard to the proportions of T cells and cells classified as "others" ( Figure 1C ) as well as CD4-CD8-T cells and g/d T cells ( Figure 1D ). The significance of changes in gene expression in entheseal digests with or without cytokine stimulation was determined by Wilcoxon's signed rank test. The Mann-Whitney U test was used to assess the significance of differences between groups in all other data sets. SPSS version 21 was used for calculation, and graphs were generated with GraphPad Prism version 6. P values less than 0.05 were considered significant.
RESULTS
Immunologic profiling of entheseal tissue. Initial assessment of total entheseal lymphocyte content revealed significant differences in the proportions of T cells in age-matched peripheral blood mononuclear cells versus entheseal soft tissue and perientheseal bone digests (P 5 0.018). There was also a significant difference in the percentage of cells not defined as T cells, B cells, or NK cells within these categories (P 5 0.016) ( Figure  1C) . Examination of T cell subsets also showed an increase in the proportion of T cells expressing neither the CD4 nor the CD8 antigen in entheseal digests compared to peripheral blood (P 5 0.021). Additionally, g/d T cell numbers were significantly increased in entheseal digests compared to peripheral blood (P 5 0.027) (Figure 1D ). ILC3 populations (defined as Lin2, CD451, RORgt1, CD32) were not detected in the normal enthesis by immunofluorescence analysis (results available upon request from the corresponding author), likely reflecting their extreme rarity under healthy conditions, necessitating a cytometric approach to ILC3 detection. Digested entheseal tissue showed the consistent presence of ILCs as identified by cell surface phenotype (5) ( Figure 1E ).
Different phenotype of ILCs detected in enthesis tissue compared to those in peripheral blood. In order to ascertain whether ILCs detected in entheseal tissue were a resident population (as distinct from passenger cells merely trapped in the vasculature), the frequency of all ILCs in peripheral blood was compared to the frequency in entheseal soft tissue and perientheseal bone digests. The proportion of ILCs was substantially greater in entheseal soft tissue compared to unmatched peripheral blood (P 5 0.008), with a median of 0.08% (range 0.03-0.20%), 0.54% (range 0.06-2.06%), and 0.24% (range 0.03-0.49%) in peripheral blood, entheseal soft tissue, and perientheseal bone, respectively ( Figure  1F ). The proportion of total ILCs identified as ILC3s and expressing the NK p44 cell surface antigen was also examined. In peripheral blood, the median percentage of lymphocytes identified as ILC3s and expressing the NK p44 marker was 0.21% (range 0-1.13%). Entheseal soft tissue digests had a significantly greater proportion of these cells (median 5.3% [range 0.8-50.9%]; P 5 0.001 versus peripheral blood), with their proportion also elevated in perientheseal bone digests (median 3.03% [range 0-13.84%]; P 5 0.043 versus peripheral blood) ( Figure 1G ).
Taken together, these data provide strong evidence that the ILC3 populations in entheseal soft tissue and perientheseal bone tissue are entheseal resident and unlikely to originate from perientheseal blood vessels. In entheseal soft tissue, ILC3s constituted a mean of 0.25% (range 0.02-0.92%) of the total lymphocyte population. NKp442 ILC3s constituted 0.16% (range 0.01-0.17%), and those expressing the NK p44 marker constituted 0.09% (range 4.25 3 10 23 20.23%). Cells phenotypically identified as ILC1s and those identified as ILC2s, respectively, constituted a mean of 0.20% (range 0-0.49%) and 0.23% (range 0-1.17%) of the total lymphocytic fraction. The proportion of ILC subsets observed in perientheseal bone was broadly similar to that in entheseal soft tissue; perientheseal bone contained fewer ILC2 populations on average, but this difference was not statistically significant.
Confirmation of ILC3 phenotype and comparison to ILC3s from SpA SF. Analysis of gene expression in ILC3s sorted from entheseal soft tissue showed a highly significant increase in the expression of RORC (RORgt) transcript compared to that in unsorted entheseal-derived mononuclear cells (P 5 0.009) (Figure  2A ), confirming the ILC3 phenotype (5) . Similar results were obtained in ILC3s isolated from perientheseal bone (P 5 0.032) ( Figure 2B ). Bars show the mean 6 SD. E-G, Expression of IL17A (E), IL17F (F), and IL22 (G) in whole entheseal digests that were stimulated with interleukin-1b (IL-1b) and IL-23 (Stim) or left untreated (control) (all n 5 7). Triangles denote values below the limit of detection, which were given assumed values of 1 3 10
25
; assumed values were also used for statistical comparison. All gene expression values shown are relative to HPRT1 expression. * 5 P , 0.05; ** 5 P , 0.01, by Mann-Whitney U test.
Since the frequency of ILC3s is known to be increased in the SF of patients with SpA (7), we compared immunomodulatory transcripts from ILC3s isolated from enthesis and from SpA SF, to further confirm the ILC3 phenotype. Transcript analysis of sorted ILC3s showed high expression of TGFB and TNFA, genes encoding mediators with opposing immunomodulatory (TGFB) and inflammatory (TNFA) roles in the context of SpA (12) . STAT3 was expressed in all tissues, indicating potential for cytokine signal transduction, but was present in significantly higher levels in perientheseal bone ILC3s compared to both entheseal soft tissue and SpA SF ILC3s (P 5 0.048) ( Figure 2C ). Expression of IL10 in ILC3s from 3 of 5 entheseal soft tissue samples and 2 of 5 perientheseal bone samples and SpA SF samples was noted. The entheseal soft tissue ILC3s had no detectable IL17A or IL22; however, IL17A message was detected in ILCs from 2 of 5 samples from normal perientheseal bone and in 1 of 4 samples from SpA SF. IL22 message was detected in 1 sample each from perientheseal bone and SpA SF (data not shown). In general, transcript expression in ILC3s isolated from enthesis tissues and ILC3s isolated from SpA SF was similar, strengthening the proposition that these cells share common functionality.
Cytokine stimulation of enthesis. Examination of IL-23 receptor expression in ILC3s isolated from either entheseal soft tissue or perientheseal bone showed a significantly increased level of IL23R transcript compared to that in unsorted mononuclear cells (P 5 0.033) (Figure 2D ), confirming the immunophenotype results and the capacity of these cells for IL-23 responsiveness. Transcriptional analysis of IL-1b/IL-23-stimulated entheseal digests showed a significant increase (P 5 0.046) in expression of IL17A after stimulation ( Figure 2E ). Expression of IL17F and IL22 also displayed a clear upward trend following stimulation, although this increase was not statistically significant ( Figures 2F and G) . These data provide functional support for the notion that human entheseal-resident cells are capable of IL-17A production in response to cytokine stimulation.
Evidence of ILC3s at sites of enthesis injury. Tissue from perientheseal regions of ruptured tendons showed inflammatory infiltrates expressing the RORgt protein; this was observed in samples from 2 of 3 donors ( Figure 3A) . Likewise, perientheseal tissue from intact ACL from donors with osteoarthritis showed cells expressing the RORgt protein in entheseal soft tissue from 5 of 7 donors ( Figure 3B ) and in perientheseal bone from 7 of 7 donors ( Figure 3C ). Positive staining for RORgt was also observed in areas of active bone remodeling in 5 of 7 patients with osteoarthritis ( Figure  3D ). For comparison, healthy spinal tissue was also examined. Positive staining was absent in 6 of 7 entheseal soft tissue samples ( Figure 3E ) as well as in control Achilles tendon (results not shown). Expression of RORgt was observed in control perientheseal bone harvested from spinous process ( Figure 3F ), and consistently present in cancellous bone harvested from iliac crest (results not shown).
DISCUSSION
Recently there has been a convergence of genetic, molecular, and therapeutic research data indicating a role of the IL-23/IL-17 axis in the pathogenesis of the SpA group of related diseases, including psoriasis and inflammatory bowel disease. With the expanding literature showing that group 3 ILCs play an important role in skin and gut homeostasis, we investigated whether ILC3 populations were present at the human enthesis, a key target tissue in early SpA. The proportion of ILC3s expressing the NK p44 marker in entheseal soft tissue and perientheseal bone confirms that these ILC3s are resident populations that could not be made-up entirely of cells released from peripheral blood vessels.
To verify the results of our phenotypic evaluation, we measured transcript for RORgt (4) , an important ILC3-lineage transcription factor, in sorted ILC3s and found it to be elevated. The detection of IL23R transcripts in ILC3 isolates provides additional confirmation of the ILC3 phenotype. Abundant TGFB was found in normal enthesis ILC3s, possibly indicating an immunoregulatory phenotype in the absence of inflammatory signaling. However, TGFB was also elevated in ILCs from SpA SF, a known inflammatory environment (7). Overall, cytokine transcript expression in ILC3 populations isolated from entheseal tissue and in those from SpA SF was very similar, perhaps indicating comparable activation states. It should be noted that in this study transcriptional analysis was limited due to the low cellular yield from sorted populations. Indeed, in many cases the expression levels of some genes of interest could not be resolved with conventional PCR. Ultra-low cell number-or single-cell-compatible techniques such as RNAseq may provide a more appropriate means of characterizing entheseal populations in the future.
After stimulation of normal whole entheseal digests with IL-1b and IL-23 there was a clear increase in IL17, and to a lesser extent, IL22, transcripts. Although this work does not address the cellular origin of these signals, it nevertheless confirms that this relatively acellular tissue is capable of responding as a whole to stimulation by increasing IL17 and IL22 transcript production. RORgt transcription factor expression was found in inflammatory infiltrates of ruptured Achilles tendon tissue and in perientheseal bone in osteoarthritis-derived enthesis. Although it is likely that cells other than ILC3s, including Th17 cells, contribute a large portion of this signal, this nevertheless highlights the involvement of the IL-23/IL-17 axis in responding to injury at the enthesis.
The elevated proportion of NKp441 ILC3s is interesting from a functional perspective since it has been shown that NKp441 ILC3s are capable of producing IL-22, whereas NKp44-ILC3s are not (5) . Given that IL-22 signaling has been implicated in promoting osteogenesis (13) , the presence of an elevated proportion of NKp441 ILC3s may suggest a potential mechanism of SpA pathogenesis related to new bone formation.
The present studies in humans were motivated by the emerging literature on ILCs and from the animal model of IL-23-dependent SpA reported by Sherlock et al (1) . Recent studies of a murine model have shown that this SpA model is associated with accumulation of g/d T cells in entheseal regions (14) . These T cells do not typically express CD4 or CD8 and have many similarities with ILC3s, particularly in their response to cytokine stimulation. Although some caution must be taken in any direct comparison between animal models and human disease, we noted that T cells that lacked expression of CD4 and CD8 were elevated in entheseal digests. Further examination of T cell subsets indicated that a high proportion of these cells were likely g/d T cells. Further characterization of this T cell subset in human enthesis is important, especially in light of the animal model data suggesting a role of g/d T cells in SpA pathogenesis (1, 14) .
In conclusion, this proof-of-concept work demonstrated that enthesis-related soft tissue and perientheseal bone harbor a population of resident ILC3s. The frequency of such cells as a proportion of CD451 lymphocytes (0.25% in entheseal soft tissue, 0.07% in perientheseal bone) is marginally lower than that reported in the gut (;0.90%) (15) and skin (0.35%) (9) . This lower frequency may be due to nonexposure of enthesis to external environments compared to the skin and gut. Further work is needed to define the exact microanatomic topography of ILC3s and to investigate for their presence in other entheses around the body, as well as to undertake studies in disease. The ability to robustly define and purify these rare cells and characterize other immune cells at sites of enthesopathy opens new avenues to explore immunity in early SpA.
